Literature DB >> 23312859

IL-21 isoform is a membrane-bound ligand and activates directly interacted cells.

Hidetoshi Nara1, Mizanur Rahman, Akemi Araki, Lianjin Jin, Yuji Takeda, Hironobu Asao.   

Abstract

IL-21 is a pleiotropic cytokine that regulates the function of T cells, B cells, natural killer cells, and myeloid cells. We previously identified an IL-21 isoform, IL-21iso, in humans and mice, and found that IL-21iso was secreted in much smaller amounts than conventional IL-21. In this study, we determined that secreted IL-21iso also has less signaling activity than IL-21. However, the amounts of intracellular IL-21 or IL-21iso, and the level of STAT3 phosphorylation induced by the two IL-21 forms, were similar. IL-21-sensitive reporter cells co-cultured with cells producing IL-21iso showed STAT3 activation, apoptosis, and proliferation. However, when IL-21iso-producing cells were cultured in a transwell chamber, which prevented direct contact with the IL-21-sensitive cells, no IL-21iso-induced signaling was observed. Though IL-21iso is secreted in smaller amounts and has less potent signaling activity than IL-21, IL-21iso acts both on IL-21iso-bearing cells and other IL-21-sensitive cells through direct interactions probably without being secreted. Thus, IL-21iso's regulation of immune cells may be limited to the immediate proximity around the IL-21iso-producing cells, in regions such as immune organs or inflammation sites.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312859     DOI: 10.1016/j.cyto.2012.12.010

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  2 in total

1.  IL-21 in cancer immunotherapy: At the right place at the right time.

Authors:  Saskia Jam Santegoets; Annelies W Turksma; Daniel J Powell; Erik Hooijberg; Tanja D de Gruijl
Journal:  Oncoimmunology       Date:  2013-04-16       Impact factor: 8.110

2.  TLR2 deficiency promotes IgE and inhibits IgG1 class-switching following ovalbumin sensitization.

Authors:  Yuqin Li; Qiu Chen; Wei Ji; Yujie Fan; Li Huang; Chu Chu; Weifang Zhou
Journal:  Ital J Pediatr       Date:  2021-07-27       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.